This study identifies a novel dystrophin homologue expressed at the neuromuscular junction that is distinct from the usual Xp21 form and is preserved in DMD patients and mdx mice.
No takes yet. Share an insight, caveat, or question.
Suggests preserved dystrophin homologue at neuromuscular junctions in DMD; leaves open its role as alternative therapeutic target.
Pons et al. (1991) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: